Literature DB >> 17886618

Pulmonary hypertension in peritoneal dialysis patients.

Lalathaksha Kumbar1, Paul A Fein, Muhammad A Rafiq, Cezary Borawski, Jyotiprakas Chattopadhyay, Morrell M Avram.   

Abstract

The information available in the literature regarding pulmonary hypertension (PH) in peritoneal dialysis (PD) patients is limited. The objective of the present study was to examine the prevalence and characteristics of PH in PD patients. We retrospectively collected the clinical profile, echocardiographic (ECHO) findings, and biochemical data for 36 PD patients for which ECHO findings were available. We compared characteristics between patients with and without PH. We found PH, defined as pulmonary arterial pressure (PAP) > or = 35 mmHg, in 15 patients. The prevalence of PH was 42%. Mean age (+/- standard deviation) of the patients with and without PH was 58 +/- 15 years and 52 +/- 15 years respectively (p = 0.30). Mean PAP of the PH patients was 43.8 +/- 9.0 mmHg (range: 35-65 mmHg). Patients with PH had a lower ejection fraction than did patients without PH (46.3% +/- 19.8% vs. 56.5% +/- 11.8% respectively, p = 0.07). Patients with PH also had a higher prevalence of global hypokinesia (60% vs. 29%, p = 0. 059) and dilated left ventricular chamber (53% vs. 19%, p = 0.03). In PH patients, body mass index (24 +/- 4.5 kg/m2 vs. 28 +/- 5.0 kg/m2, p = 0.024), normalized protein catabolic rate (0. 78 +/- 0.21 g/kg vs. 0.95 +/- 0.27 g/kg daily, p = 0.049), and ferritin (226 +/- 210 ng/mL vs. 873 +/- 965 ng/mL, p = 0.005) were significantly lower and lactate dehydrogenase was higher (264 +/- 99 U/L vs. 206 +/- 79 U/L, p = 0.06) than in patients without PH. We observed no significant differences in race or sex, incidence of hypertension or cardiovascular disease, or vitamin D analog use between the two groups of patients. During the study period, 60% of PH patients and 38% of patients without PH died (p = 0.19). Values of PAP correlated directly with serum levels of phosphorus (r = 0.44, p = 0.02), CaxP product (r = 0.40, p = 0.04), and parathyroid hormone (r = 0.42, p = 0.03). Of continuous ambulatory PD and continuous cycling PD patients, 21% and 55% respectively had PH (p = 0. 049). In PD patients, PH is highly prevalent and may be associated with higher mortality risk.

Entities:  

Mesh:

Year:  2007        PMID: 17886618

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  16 in total

1.  Pulmonary hypertension in end-stage renal disease and post renal transplantation patients.

Authors:  Esam H Alhamad; Mohammed Al-Ghonaim; Hussam F Alfaleh; Joseph P Cal; Nazmi Said
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

2.  Association of Pulmonary Hypertension with Mortality in Incident Peritoneal Dialysis Patients.

Authors:  Qingdong Xu; Liping Xiong; Li Fan; Fenghua Xu; Yan Yang; Huiyan Li; Xuan Peng; Shirong Cao; Zhihua Zheng; Xiao Yang; Xueqing Yu; Haiping Mao
Journal:  Perit Dial Int       Date:  2014-09-02       Impact factor: 1.756

3.  Echocardiographic Pulmonary Hypertension Predicts Post-transplantation Renal Allograft Failure.

Authors:  A E Foderaro; G L Baird; A Bazargan-Lari; P E Morrissey; R Y Gohh; A Poppas; J R Klinger; C E Ventetuolo
Journal:  Transplant Proc       Date:  2017 Jul - Aug       Impact factor: 1.066

4.  Prevalence of pulmonary hypertension in peritoneal dialysis patients: a meta-analysis.

Authors:  Yuanyuan Li; Weifeng Shang; Qiaofa Lu; Bo Zhang; Yali Ren; Yanbo Sun; Junwu Dong
Journal:  Int Urol Nephrol       Date:  2018-11-19       Impact factor: 2.370

5.  Pulmonary hypertension in dialysis patients: a cross-sectional italian study.

Authors:  Fabio Fabbian; Stefano Cantelli; Christian Molino; Marco Pala; Carlo Longhini; Francesco Portaluppi
Journal:  Int J Nephrol       Date:  2010-09-30

6.  Pulmonary hypertension complicating multiple myeloma.

Authors:  Udhay Krishnan; Tomer M Mark; Ruben Niesvizky; Irina Sobol
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

7.  Relationship between pulmonary hypertension, peripheral vascular calcification, and major cardiovascular events in dialysis patients.

Authors:  Sun Chul Kim; Hyo Jung Chang; Myung-Gyu Kim; Sang-Kyung Jo; Won-Yong Cho; Hyoung-Kyu Kim
Journal:  Kidney Res Clin Pract       Date:  2015-01-30

8.  The potential effect of cardiac function on pulmonary hypertension, other risk factors, and its impact on survival in dialysis patients.

Authors:  Merita Rroji; Majlinda Cafka; Saimir Seferi; Joana Seiti; Myftar Barbullushi; Artan Goda
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

9.  Renal transplant improves pulmonary hypertension in patients with end stage renal disease.

Authors:  Serife Savas Bozbas; Suleyman Kanyilmaz; Sule Akcay; Huseyin Bozbas; Cihan Altin; Emir Karacaglar; Haldun Muderrisoglu; Mehmet Haberal
Journal:  Multidiscip Respir Med       Date:  2011-06-30

10.  Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension.

Authors:  Silvia Ulrich; Martin Hersberger; Manuel Fischler; Lars C Huber; Oliver Senn; Ursula Treder; Rudolf Speich; Christoph Schmid
Journal:  Open Respir Med J       Date:  2009-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.